Natural history and treatment of fibrous dysplasia of bone: A multicenter clinicopathologic study promoted by the European Pediatric Orthopaedic Society

Journal of Pediatric Orthopaedics Part B

Volumn 12, Issue 3, 2003, Pages 155-177

  Ippolito, Ernesto ^a   Bray, Edward W ^b   Corsi, Alessandro ^c   De Maio, Fernando ^d   Exner, Ulrich G ^e   Gehron Robey, Pamela ^f   Grill, Franz ^g   Lala, Roberto ^h   Massobrio, Marco ^d   Pinggera, Oswald ^g   Riminucci, Mara ^c   Snela, Slawomir ⁱ   Zambakidis, Christos ^j   Blanco, Paolo ^d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Shriner's Children's Hospital   (United States)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

^f NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^g Institut für Physikalische Medizin und Orthopädische Rehabilitation   (Austria)

^h REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

ⁱ Szpital Wojewodski   (Poland)

^j P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

more..

Author keywords

Fibrous dysplasia; GNAS1 mutations; Intramedullary nailing; McCune Albright syndrome; Orthopedic surgery; Pathology

Indexed keywords

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; BONE RADIOGRAPHY; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DNA EXTRACTION; ENDOCRINE FUNCTION; FACE FRACTURE; FEMALE; FEMUR FRACTURE; FIBROUS DYSPLASIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTRAMEDULLARY NAIL; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MOLECULAR GENETICS; OSTEOSYNTHESIS; PHOSPHATE METABOLISM; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TIBIA FRACTURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; FEMORAL FRACTURES; FEMUR; FIBROUS DYSPLASIA OF BONE; FRACTURE FIXATION, INTRAMEDULLARY; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; HUMERAL FRACTURES; HUMERUS; INTERNAL FIXATORS; MALE; MUTATION, MISSENSE; RISK FACTORS; SPINE; TIBIA; TIBIAL FRACTURES;

EID: 0037911376     PISSN: 1060152X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00009957-200305000-00001     Document Type: Review

References (42)

1. Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg 1938; 36:874-879.
2. Lichtenstein L, Jaffe HL. Fibrous dysplasia of bone: a condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism and still other extraskeletal abnormalities. Arch Pathol 1942; 33:777-797.
3. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N Engl J Med 1937; 216:727-746.
4. Albright F, Scoville B, Sulkowitch HW. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and a gonadal dysfunction: further observations including the report of two more cases. Endocrinology 1938; 22:411-421.
5. Feuillan PP. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1997; 6:235-239.
6. Harris WH, Dudley HR, Barry RJ. The natural history of fibrous dysplasia. J Bone Joint Surg Am 1962; 44A:207-233.
7. McCune DJ, Bruch H. Progress in pediatrics: osteodystrophia fibrosa. Am J Dis Child 1937; 54:806-848.
8. Mazabraud A, Girard J. Un cas particulier de dysplasis fibreuse a localisations osseuses et tendineuses [in French]. Rev Rhum 1957; 34:652-659.
9. Mazabraud A, Semat P, Rose R. A propos de l'association de fibromixomes des tissus mous a la dysplasie fibreuse de l'os [in French]. Press Med 1967; 75:2223-2228.
10. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 1992; 89:5152-5156.
11. Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994; 79:750-755.
12. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325:1688-1695.
13. Spiegel AM. Inborn errors of signal transduction: mutations in G proteins and G protein-coupled receptors as a cause of disease. J Inherit Metab Dis 1997; 20:113-121.
14. Spiegel AM. The molecular basis of disorders caused by defects in G proteins. Horm Res 1997; 47:89-96.
15. Bianco P, Kuznetsov S, Riminucci M, Fisher LW, Spiegel AM, Gehron Robey P. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs-alpha mutated skeletal progenitor cells. J Clin Invest 1998; 101:1737-1744.
16. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000; 15:120-128.
17. Marie PJ, de Pollak C, Chanson P, Lomri A. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 1997; 150:1059-1069.
18. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997; 151:1587-1600.
19. Shenker A, Chanson P, Weinstein LS, Chi P, Spiegel AM, Lomri A, Marie PJ. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet 1995; 4:1675-1676.
20. Bianco P, Gehron Robey P, Wientroub S. Fibrous dysplasia of bone. In: Glorieux HJ (editor): Pediatric bone biology and disease. New York: Academic Press; (in press).
21. Dorfman HD, Czerniak B. Bone tumors. St. Louis: Mosby; 1997.
22. Andrisano A, Soncini G, Calderoni PP, Stilli S. Critical review of infantile fibrous dysplasia: surgical treatment. J Pediatr Orthop 1991; 11:478-481.
23. Enneking WF, Gearen PF. Fibrous dysplasia of the femoral neck. J Bone Joint Surg Am 1986; 68A:1415-1422.
24. Guille JT, Kumar SJ, MacEwen GD. Fibrous dysplasia of the proximal part of the femur. J Bone Joint Surg Am 1998; 80A:648-658.
25. Kumta SM, Leung PC, Griffith JF, Kew J, Chow LTC. Vascularized bone grafting for fibrous dysplasia of the upper limb. J Bone Joint Surg Br 2000; 82B:409-412.
26. Stephenson RB, London MD, Hankin FM, Kaufer H. Fibrous dysplasia. J Bone Joint Surg Am 1987; 69A:400-409.
27. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12:1746-1752.
28. Lala R, Matarazzo P, Bertelloni S, Buzi F, Rigon F, de Sanctis C. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome. Acta Paediatr 2000; 89:188-193.
29. Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994; 343:953-954.
30. Zacharin M, O'Sullivan M. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome. J Pediatr 2000; 137:403-409.
31. Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 2001; 16:806-813.
32. Akintoye S, Chebli C, Booher S, Feuillan P, Kushner H, LeRoith D, et al. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright Syndrome. J Clin End Metab 2002; 87:5104-5112.
33. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994; 131:229-234.
34. Feuillan PP. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1994; 5:205-209.
35. Corsi A, Collins MT, Mankani MH, Gehron Robey P, Bianco P. Core biopsy studies of fibrous dysplasia of bone: evidence for impaired mineralization of lesional bone and for hormonal dependency of turnover within the lesion [Abstract]. J Bone Min Res 2000; 15S:485.
36. Riminucci M, Collins M, Corsi A, Boyde A, Murphey MD, Wientroub S, et al. Gnatho-diaphyseal dysplasia: a syndrome of fibro-osseous lesions of jawbones, bone fragility, and long bone bowing. J Bone Miner Res 2001; 16:1710-1718.
37. Collins MT, Riminucci M, Corsi A, Murphey MD, Wientroub S, Bianco P, Gehron Robey P. Angiomatosis of bone with localized mineralization defect. J Bone Miner Res 2001; 16:1750-1753.
38. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Gehron Robey P, Bianco P. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 1999; 187:249-258.
39. Park YK, Unni KK, McLeod RA, Pritchard DJ. Osteofibrous dysplasia: clinicopathologic study of 80 cases. Hum Pathol 1993; 24:1339-1347.
40. Sakamoto A, Oda Y, Iwamoto Y, Tsuneyoshi M. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gs alpha mutation at the Arg201 codon: polymerase chain reaction- restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn 2000; 2:67-72.
41. Freeman BH, Bray EW, Meyer LC. Multiple osteotomies with Zickel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur. J Bone Joint Surg Am 1987; 69A:691-698.
42. O'Sullivan M, Zacharin M. Intramedullary rodding and bisphosphonate treatment of polyostotic fibrous dysplasia associated with the McCuneAlbright syndrome. J Pediatr Orthop 2002; 22:255-260.